Biotech · Private company
Synchroneuron Inc.
Track this companyFree. Adds Synchroneuron Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- SNC-102Phase 2 · Drug-induced Tardive DyskinesiaClinicalTrials.gov · fetched Nov 12, 2026
- SNC-102 sustained release tabletPhase 2 · Tourette SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette SyndromePHASE2 · WITHDRAWN · started Apr 1, 2015ClinicalTrials.gov NCT02217007 · fetched Nov 12, 2026
- A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive DyskinesiaPHASE2 · WITHDRAWN · started Feb 1, 2014ClinicalTrials.gov NCT02064010 · fetched Nov 12, 2026